Low-dose aspirin refers to aspirin taken at 75 to 325 mg per day, most commonly as an 81 mg tablet in the United States. Unlike the higher doses used for pain relief (500 to 1,000 mg), low-dose aspirin is taken daily to prevent blood clots that can lead to heart attacks and strokes. It’s one of the most widely used preventive medications in the world, but guidelines on who should take it have shifted significantly in recent years.
How Low-Dose Aspirin Works
Aspirin permanently disables an enzyme in platelets, the tiny blood cells responsible for clotting. With that enzyme knocked out, platelets can no longer produce a chemical signal called thromboxane A2 that tells them to clump together. Since platelets can’t repair themselves, each one affected by aspirin stays disabled for the rest of its lifespan, roughly 7 to 10 days. Your body replaces about 10% of its platelets each day, so a single daily low dose is enough to keep the majority of circulating platelets in a less “sticky” state at all times.
This is why low-dose aspirin is effective at such a small amount. You don’t need enough aspirin to reduce pain or inflammation. You just need enough to reach the platelets passing through your bloodstream before the liver breaks the drug down.
Who Benefits From Taking It
The clearest benefit is for people who have already had a heart attack, stroke, or other cardiovascular event. For these patients, daily low-dose aspirin is a cornerstone of what doctors call secondary prevention, reducing the likelihood of a second event. This group gets the strongest recommendation to stay on aspirin long-term.
For people who have never had a cardiovascular event, the picture is more complicated. The 2022 US Preventive Services Task Force guidelines recommend considering aspirin only for adults aged 40 to 59 who have a 10-year cardiovascular risk of 10% or greater and are not at increased risk of bleeding. For adults 60 and older without a history of cardiovascular disease, the task force recommends against starting aspirin for prevention, because the bleeding risks tend to outweigh the benefits as people age.
Prevention of Preeclampsia in Pregnancy
Low-dose aspirin also has an important role in pregnancy. The USPSTF recommends 81 mg per day for pregnant people at high risk of preeclampsia, starting after 12 weeks of gestation. The American College of Obstetricians and Gynecologists echoes this, noting that treatment should ideally begin before 16 weeks and continue daily until delivery. Effective dosages in clinical studies ranged from 60 to 150 mg per day, but the standard 81 mg tablet is considered a reasonable dose for this purpose.
Bleeding Risks
The same anti-clotting effect that protects arteries also makes bleeding more likely. The most common concern is gastrointestinal bleeding. A large systematic review of observational studies found that low-dose aspirin increases the overall risk of GI bleeding by about 40%. For upper GI bleeding specifically (stomach and upper intestine), the risk roughly doubles. In absolute terms, the incidence of GI bleeding among aspirin users runs between 0.48 and 3.64 cases per 1,000 people per year, meaning it’s uncommon for any individual but significant across a large population.
Intracranial bleeding is rarer but more serious. A study of over 19,000 healthy older adults found a statistically significant 38% increase in intracranial bleeding (combining hemorrhagic strokes and other causes) among those randomized to aspirin. Hemorrhagic stroke alone was slightly more common in the aspirin group (0.5% vs. 0.4%), though that difference was not statistically significant on its own. These numbers help explain why guidelines now discourage routine aspirin use in older adults who haven’t had a cardiovascular event.
Why You Shouldn’t Stop Abruptly
If you’ve been taking low-dose aspirin for a year or more, stopping suddenly can be dangerous. A large Swedish study of over 600,000 long-term aspirin users found that 15% spontaneously discontinued the drug. Those who stopped experienced a 37% increase in cardiovascular events compared to those who continued. Among people taking aspirin for secondary prevention (after a prior heart attack or stroke), the increase was 46%. Even among primary prevention users, stopping was associated with a 28% rise in events.
This translates to roughly one additional cardiovascular event for every 74 patients who stop aspirin each year. Researchers attribute this partly to a biological rebound effect: once aspirin’s suppression of platelet activity lifts, platelets may become temporarily more reactive than they were before treatment ever started. The takeaway is straightforward. If you and your doctor decide to stop aspirin, it should be a deliberate, planned decision, not something you drift away from on your own.
The Ibuprofen Interaction
One of the most practically important things to know about low-dose aspirin is that common painkillers like ibuprofen can block its antiplatelet effect. If ibuprofen reaches your platelets first, it temporarily occupies the same enzyme site that aspirin needs to bind to permanently. The result: aspirin passes through without doing its job.
The FDA advises a simple timing rule. If you take immediate-release (non-enteric-coated) low-dose aspirin, take it at least 30 minutes before ibuprofen. If you’ve already taken ibuprofen, wait at least 8 hours before taking your aspirin. Enteric-coated aspirin is trickier because it dissolves more slowly, and at least one study showed that ibuprofen taken 2, 7, or even 12 hours after enteric-coated aspirin still interfered with platelet inhibition. If you rely on aspirin for cardiovascular protection and regularly use ibuprofen for pain, this interaction is worth discussing with your pharmacist or doctor.
What “Low Dose” Actually Means in Practice
In the US, low-dose aspirin almost always means the 81 mg “baby aspirin” tablet, available over the counter. In Europe and other countries, 75 mg and 100 mg formulations are common. Clinical guidelines define the low-dose range as 75 to 325 mg daily, and studies suggest that 325 mg appears to be at least as effective as 75 mg for preventing cardiovascular and cerebrovascular events. However, higher doses within this range carry a greater bleeding risk, which is why most current practice has settled on the lower end.
Low-dose aspirin comes in both immediate-release and enteric-coated versions. Enteric coating is designed to dissolve in the intestine rather than the stomach, theoretically reducing stomach irritation. In practice, the evidence that enteric coating meaningfully reduces GI bleeding is limited, and as noted above, the coating can complicate drug interactions by slowing absorption.